Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure. - Granberg KL; Sakamaki S; Larsson N; Bergström F; Fuchigami R; Niwa Y; Ryberg E; Backmark A; Kato H; Miyazaki S; Iguchi K; Sakamoto T; et al. (Journal of medicinal chemistry, 2024)